AVXL
Price
$9.53
Change
-$0.10 (-1.04%)
Updated
Apr 30, 10:32 AM (EDT)
Capitalization
819.17M
8 days until earnings call
NTLA
Price
$8.07
Change
-$0.13 (-1.59%)
Updated
Apr 30, 11:09 AM (EDT)
Capitalization
848.84M
One day until earnings call
Ad is loading...

AVXL vs NTLA

Header iconAVXL vs NTLA Comparison
Open Charts AVXL vs NTLABanner chart's image
Anavex Life Sciences
Price$9.53
Change-$0.10 (-1.04%)
Volume$461
Capitalization819.17M
Intellia Therapeutics
Price$8.07
Change-$0.13 (-1.59%)
Volume$4.12K
Capitalization848.84M
AVXL vs NTLA Comparison Chart
Loading...
AVXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVXL vs. NTLA commentary
Apr 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVXL is a StrongBuy and NTLA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 30, 2025
Stock price -- (AVXL: $9.63 vs. NTLA: $8.20)
Brand notoriety: AVXL and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVXL: 42% vs. NTLA: 83%
Market capitalization -- AVXL: $819.17M vs. NTLA: $848.84M
AVXL [@Biotechnology] is valued at $819.17M. NTLA’s [@Biotechnology] market capitalization is $848.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $279.46B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVXL’s FA Score shows that 0 FA rating(s) are green whileNTLA’s FA Score has 1 green FA rating(s).

  • AVXL’s FA Score: 0 green, 5 red.
  • NTLA’s FA Score: 1 green, 4 red.
According to our system of comparison, both AVXL and NTLA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVXL’s TA Score shows that 7 TA indicator(s) are bullish while NTLA’s TA Score has 4 bullish TA indicator(s).

  • AVXL’s TA Score: 7 bullish, 3 bearish.
  • NTLA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, AVXL is a better buy in the short-term than NTLA.

Price Growth

AVXL (@Biotechnology) experienced а +4.56% price change this week, while NTLA (@Biotechnology) price change was -1.32% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.16%. For the same industry, the average monthly price growth was +1.72%, and the average quarterly price growth was -10.51%.

Reported Earning Dates

AVXL is expected to report earnings on Aug 12, 2025.

NTLA is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+1.16% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($849M) and AVXL($819M) have the same market capitalization . AVXL YTD gains are higher at: -10.335 vs. NTLA (-29.674). AVXL has higher annual earnings (EBITDA): -45.2M vs. NTLA (-523.98M). NTLA has more cash in the bank: 602M vs. AVXL (121M). AVXL has less debt than NTLA: AVXL (88.2K) vs NTLA (210M). NTLA has higher revenues than AVXL: NTLA (57.9M) vs AVXL (0).
AVXLNTLAAVXL / NTLA
Capitalization819M849M96%
EBITDA-45.2M-523.98M9%
Gain YTD-10.335-29.67435%
P/E RatioN/AN/A-
Revenue057.9M-
Total Cash121M602M20%
Total Debt88.2K210M0%
FUNDAMENTALS RATINGS
AVXL vs NTLA: Fundamental Ratings
AVXL
NTLA
OUTLOOK RATING
1..100
134
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
26
Undervalued
PROFIT vs RISK RATING
1..100
74100
SMR RATING
1..100
9797
PRICE GROWTH RATING
1..100
3664
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NTLA's Valuation (26) in the Biotechnology industry is somewhat better than the same rating for AVXL (62). This means that NTLA’s stock grew somewhat faster than AVXL’s over the last 12 months.

AVXL's Profit vs Risk Rating (74) in the Biotechnology industry is in the same range as NTLA (100). This means that AVXL’s stock grew similarly to NTLA’s over the last 12 months.

AVXL's SMR Rating (97) in the Biotechnology industry is in the same range as NTLA (97). This means that AVXL’s stock grew similarly to NTLA’s over the last 12 months.

AVXL's Price Growth Rating (36) in the Biotechnology industry is in the same range as NTLA (64). This means that AVXL’s stock grew similarly to NTLA’s over the last 12 months.

AVXL's P/E Growth Rating (100) in the Biotechnology industry is in the same range as NTLA (100). This means that AVXL’s stock grew similarly to NTLA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVXLNTLA
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 3 days ago
77%
Declines
ODDS (%)
Bearish Trend 27 days ago
80%
Bearish Trend 15 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
AVXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA292.036.15
+2.15%
Tesla
SPY554.323.47
+0.63%
SPDR® S&P 500® ETF
AAPL211.211.07
+0.51%
Apple
BTC.X94284.790000-693.960940
-0.73%
Bitcoin cryptocurrency
GME27.26-0.33
-1.20%
GameStop Corp

AVXL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVXL has been loosely correlated with PLRX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AVXL jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVXL
1D Price
Change %
AVXL100%
+0.52%
PLRX - AVXL
47%
Loosely correlated
+0.68%
TENX - AVXL
45%
Loosely correlated
-3.52%
RXRX - AVXL
44%
Loosely correlated
-2.05%
NTLA - AVXL
42%
Loosely correlated
-3.30%
KALV - AVXL
40%
Loosely correlated
+0.62%
More

NTLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been loosely correlated with CRSP. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if NTLA jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
-3.30%
CRSP - NTLA
66%
Loosely correlated
-1.27%
BEAM - NTLA
64%
Loosely correlated
-0.45%
RXRX - NTLA
60%
Loosely correlated
-2.05%
RCKT - NTLA
59%
Loosely correlated
+1.68%
ABCL - NTLA
58%
Loosely correlated
-1.54%
More